Final Exam: NR 568 / NR568 (Latest Update 2026/2027) Advanced Pharmacology for the
Adult-Gerontology Primary Care Nurse Practitioner | Questions with Answers | 100% Correct | Grade A -
Chamberlain 2026/2027 - 2026/2027 Official Exam
OBJECTIVE ASSESSMENT - EXAM
Final Exam: NR 568 / NR568 (Latest Update 2026/2027) Advanced
Pharmacology for the Adult-Gerontology Primary Care Nurse Practitioner |
Questions with Answers | 100% Correct | Grade A - Chamberlain 2026/2027 -
2026/2027 Official Exam
100 100%
QUESTIONS VERIFIED ANSWERS EDITION
TOPICS COVERED
Pharmacokinetics & Pharmacodynamics Neurological & Psychiatric Pharmacology
Cardiovascular & Renal Pharmacology Anti-infectives & Chemotherapy
Endocrine & Reproductive Pharmacology Geriatric Pharmacology & Polypharmacy
COVER PAGE - 1
, SECTION 1 | Pharmacokinetics & Pharmacodynamics | Q1-Q17 | Final Exam: NR 568 / NR568 (Latest Update 2026/2027) Advanced Pharmacology for the Adult-Gerontology Primary Care N
Q1 Question 1 of 100
A 68-year-old male with new-onset atrial fibrillation is started on warfarin 5 mg daily. The
provider explains that steady-state concentration will be achieved after approximately 4 to
5 half-lives, and the half-life of warfarin is roughly 36 to 42 hours. The patient asks how
many days it will take to reach steady state. Approximately how many days are required
to achieve steady-state warfarin levels?
A. 7 to 9 days
B. 1 to 2 days
C. 24 hours
D. 30 days
Correct Answer: A
Rationale:
Steady state is reached after 4 to 5 half-lives. With a warfarin half-life of about 36 to 42 hours, 5
half-lives equals 180 to 210 hours, or 7.5 to 8.75 days. This is why warfarin requires bridging with
heparin for acute thromboembolism. One to two days is far too short, 24 hours reflects only about half of
one half-life, and 30 days greatly overestimates the time needed.
Q2 Question 2 of 100
A 72-year-old female takes oral levothyroxine 100 mcg each morning on an empty
stomach. She recently started taking a calcium carbonate antacid with her levothyroxine
and now reports persistent fatigue and a rising TSH. Which pharmacokinetic process is
most directly affected by this interaction?
A. Distribution
B. Absorption
C. Metabolism
D. Excretion
Correct Answer: B
Rationale:
Calcium carbonate complexes with levothyroxine in the intestinal lumen, reducing drug absorption and
leading to lower serum thyroxine levels and a compensatory rise in TSH. Levothyroxine should be taken
on an empty stomach, separated from calcium, iron, and other binders by at least 4 hours. The
interaction does not affect distribution, hepatic metabolism, or renal excretion.
Final Exam: NR 568 / NR568 (Latest Update 2026/2027) Advanced Pharmacology for the Adult-Ger -- 2026/2027 | Passing Score: 80% | Page 2 of 53
, Q3 Question 3 of 100
A 55-year-old male with hypertension has been prescribed oral propranolol 40 mg twice
daily. The provider notes that the bioavailability of propranolol is only about 25% despite
nearly complete gastrointestinal absorption. Which pharmacokinetic phenomenon best
explains the reduced bioavailability of propranolol?
A. Renal tubular reabsorption
B. Hepatic enzyme induction
C. First-pass metabolism
D. Plasma protein binding
Correct Answer: C
Rationale:
Propranolol undergoes extensive hepatic first-pass metabolism, so a large fraction of the orally
absorbed dose is removed by the liver before reaching the systemic circulation, lowering oral
bioavailability to roughly 25%. This is why oral doses are much higher than equivalent IV doses. Renal
reabsorption, enzyme induction, and protein binding do not explain the low systemic availability.
Q4 Question 4 of 100
A 60-year-old female with generalized tonic-clonic seizures is on long-term phenytoin
therapy at stable doses. She is admitted with nystagmus, ataxia, and confusion after
starting cimetidine for gastroesophageal reflux. The phenytoin level is markedly elevated.
Which mechanism most accurately explains this drug interaction?
A. Phenytoin induces CYP3A4, lowering cimetidine levels
B. Phenytoin increases renal clearance of cimetidine
C. Cimetidine induces phenytoin metabolism
D. Cimetidine inhibits CYP-mediated phenytoin metabolism
Correct Answer: D
Rationale:
Cimetidine is a nonspecific inhibitor of hepatic cytochrome P450 enzymes, including CYP2C9 and
CYP2C19, which metabolize phenytoin. Inhibition of these enzymes reduces phenytoin clearance,
causing plasma levels to rise into the toxic range. Phenytoin itself is an enzyme inducer but does not
lower cimetidine in a clinically meaningful way, and renal clearance is not the primary pathway affected.
Final Exam: NR 568 / NR568 (Latest Update 2026/2027) Advanced Pharmacology for the Adult-Ger -- 2026/2027 | Passing Score: 80% | Page 3 of 53
, Q5 Question 5 of 100
A patient receives a loading dose of digoxin to rapidly achieve therapeutic serum
concentrations. The provider explains that a loading dose is necessary for drugs with a
long half-life and that the dose is calculated from a specific pharmacokinetic parameter.
Which parameter most directly determines the loading dose required to reach a target
plasma concentration?
A. Volume of distribution
B. Bioavailability
C. Half-life
D. Clearance
Correct Answer: A
Rationale:
The loading dose is calculated as the desired plasma concentration multiplied by the volume of
distribution (adjusted for bioavailability). Volume of distribution reflects the apparent space in which the
drug disperses, so a larger Vd requires a larger loading dose. Half-life and clearance determine
maintenance dosing and time to steady state, not the loading dose itself.
Q6 Question 6 of 100
A 50-year-old male with bipolar disorder is treated with lithium. He presents with
confusion, coarse tremor, and ataxia after starting hydrochlorothiazide 25 mg daily for
hypertension. The lithium level is 2.4 mEq/L. What pharmacokinetic mechanism is
responsible for the rise in lithium levels?
A. Increased glomerular filtration of lithium
B. Increased renal reabsorption of lithium
C. Decreased hepatic metabolism of lithium
D. Increased plasma protein binding of lithium
Correct Answer: B
Rationale:
Thiazide diuretics increase sodium loss in the distal tubule, which causes the kidneys to compensate by
reabsorbing more sodium (and lithium, which is handled similarly) in the proximal tubule. The enhanced
reabsorption reduces lithium clearance and raises plasma levels into the toxic range. Lithium is not
metabolized hepatically, has negligible protein binding, and thiazides do not increase its filtration.
Final Exam: NR 568 / NR568 (Latest Update 2026/2027) Advanced Pharmacology for the Adult-Ger -- 2026/2027 | Passing Score: 80% | Page 4 of 53
Adult-Gerontology Primary Care Nurse Practitioner | Questions with Answers | 100% Correct | Grade A -
Chamberlain 2026/2027 - 2026/2027 Official Exam
OBJECTIVE ASSESSMENT - EXAM
Final Exam: NR 568 / NR568 (Latest Update 2026/2027) Advanced
Pharmacology for the Adult-Gerontology Primary Care Nurse Practitioner |
Questions with Answers | 100% Correct | Grade A - Chamberlain 2026/2027 -
2026/2027 Official Exam
100 100%
QUESTIONS VERIFIED ANSWERS EDITION
TOPICS COVERED
Pharmacokinetics & Pharmacodynamics Neurological & Psychiatric Pharmacology
Cardiovascular & Renal Pharmacology Anti-infectives & Chemotherapy
Endocrine & Reproductive Pharmacology Geriatric Pharmacology & Polypharmacy
COVER PAGE - 1
, SECTION 1 | Pharmacokinetics & Pharmacodynamics | Q1-Q17 | Final Exam: NR 568 / NR568 (Latest Update 2026/2027) Advanced Pharmacology for the Adult-Gerontology Primary Care N
Q1 Question 1 of 100
A 68-year-old male with new-onset atrial fibrillation is started on warfarin 5 mg daily. The
provider explains that steady-state concentration will be achieved after approximately 4 to
5 half-lives, and the half-life of warfarin is roughly 36 to 42 hours. The patient asks how
many days it will take to reach steady state. Approximately how many days are required
to achieve steady-state warfarin levels?
A. 7 to 9 days
B. 1 to 2 days
C. 24 hours
D. 30 days
Correct Answer: A
Rationale:
Steady state is reached after 4 to 5 half-lives. With a warfarin half-life of about 36 to 42 hours, 5
half-lives equals 180 to 210 hours, or 7.5 to 8.75 days. This is why warfarin requires bridging with
heparin for acute thromboembolism. One to two days is far too short, 24 hours reflects only about half of
one half-life, and 30 days greatly overestimates the time needed.
Q2 Question 2 of 100
A 72-year-old female takes oral levothyroxine 100 mcg each morning on an empty
stomach. She recently started taking a calcium carbonate antacid with her levothyroxine
and now reports persistent fatigue and a rising TSH. Which pharmacokinetic process is
most directly affected by this interaction?
A. Distribution
B. Absorption
C. Metabolism
D. Excretion
Correct Answer: B
Rationale:
Calcium carbonate complexes with levothyroxine in the intestinal lumen, reducing drug absorption and
leading to lower serum thyroxine levels and a compensatory rise in TSH. Levothyroxine should be taken
on an empty stomach, separated from calcium, iron, and other binders by at least 4 hours. The
interaction does not affect distribution, hepatic metabolism, or renal excretion.
Final Exam: NR 568 / NR568 (Latest Update 2026/2027) Advanced Pharmacology for the Adult-Ger -- 2026/2027 | Passing Score: 80% | Page 2 of 53
, Q3 Question 3 of 100
A 55-year-old male with hypertension has been prescribed oral propranolol 40 mg twice
daily. The provider notes that the bioavailability of propranolol is only about 25% despite
nearly complete gastrointestinal absorption. Which pharmacokinetic phenomenon best
explains the reduced bioavailability of propranolol?
A. Renal tubular reabsorption
B. Hepatic enzyme induction
C. First-pass metabolism
D. Plasma protein binding
Correct Answer: C
Rationale:
Propranolol undergoes extensive hepatic first-pass metabolism, so a large fraction of the orally
absorbed dose is removed by the liver before reaching the systemic circulation, lowering oral
bioavailability to roughly 25%. This is why oral doses are much higher than equivalent IV doses. Renal
reabsorption, enzyme induction, and protein binding do not explain the low systemic availability.
Q4 Question 4 of 100
A 60-year-old female with generalized tonic-clonic seizures is on long-term phenytoin
therapy at stable doses. She is admitted with nystagmus, ataxia, and confusion after
starting cimetidine for gastroesophageal reflux. The phenytoin level is markedly elevated.
Which mechanism most accurately explains this drug interaction?
A. Phenytoin induces CYP3A4, lowering cimetidine levels
B. Phenytoin increases renal clearance of cimetidine
C. Cimetidine induces phenytoin metabolism
D. Cimetidine inhibits CYP-mediated phenytoin metabolism
Correct Answer: D
Rationale:
Cimetidine is a nonspecific inhibitor of hepatic cytochrome P450 enzymes, including CYP2C9 and
CYP2C19, which metabolize phenytoin. Inhibition of these enzymes reduces phenytoin clearance,
causing plasma levels to rise into the toxic range. Phenytoin itself is an enzyme inducer but does not
lower cimetidine in a clinically meaningful way, and renal clearance is not the primary pathway affected.
Final Exam: NR 568 / NR568 (Latest Update 2026/2027) Advanced Pharmacology for the Adult-Ger -- 2026/2027 | Passing Score: 80% | Page 3 of 53
, Q5 Question 5 of 100
A patient receives a loading dose of digoxin to rapidly achieve therapeutic serum
concentrations. The provider explains that a loading dose is necessary for drugs with a
long half-life and that the dose is calculated from a specific pharmacokinetic parameter.
Which parameter most directly determines the loading dose required to reach a target
plasma concentration?
A. Volume of distribution
B. Bioavailability
C. Half-life
D. Clearance
Correct Answer: A
Rationale:
The loading dose is calculated as the desired plasma concentration multiplied by the volume of
distribution (adjusted for bioavailability). Volume of distribution reflects the apparent space in which the
drug disperses, so a larger Vd requires a larger loading dose. Half-life and clearance determine
maintenance dosing and time to steady state, not the loading dose itself.
Q6 Question 6 of 100
A 50-year-old male with bipolar disorder is treated with lithium. He presents with
confusion, coarse tremor, and ataxia after starting hydrochlorothiazide 25 mg daily for
hypertension. The lithium level is 2.4 mEq/L. What pharmacokinetic mechanism is
responsible for the rise in lithium levels?
A. Increased glomerular filtration of lithium
B. Increased renal reabsorption of lithium
C. Decreased hepatic metabolism of lithium
D. Increased plasma protein binding of lithium
Correct Answer: B
Rationale:
Thiazide diuretics increase sodium loss in the distal tubule, which causes the kidneys to compensate by
reabsorbing more sodium (and lithium, which is handled similarly) in the proximal tubule. The enhanced
reabsorption reduces lithium clearance and raises plasma levels into the toxic range. Lithium is not
metabolized hepatically, has negligible protein binding, and thiazides do not increase its filtration.
Final Exam: NR 568 / NR568 (Latest Update 2026/2027) Advanced Pharmacology for the Adult-Ger -- 2026/2027 | Passing Score: 80% | Page 4 of 53
